|Articles|September 1, 2014
- BioPharm International-09-01-2014
- Volume 27
- Issue 9
BioPharm International, September 2014 Issue (PDF)
Click the title above to open the BioPharm International September 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Optimizing Human Performance: A Road Worth Traveling, Part 3over 11 years ago
Healthcare Reform in Chinaover 11 years ago
Extending the Scope of Pharmacovigilance Comes at a Priceover 11 years ago
Targeting Different Off-Shore Destinationsover 11 years ago
Data Integrity Key to GMP Complianceover 11 years ago
Challenges of Protein Aggregation during Purificationover 11 years ago
Minimizing Variation in Vial Withdrawal Practiceover 11 years ago
Quality Agreements for Contract Manufacturersover 11 years ago
The Relevance of Industry Technical Associationsover 11 years ago
Managing Cleaning Validation in Multi-Product Biologics FacilitiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
